4153.TWO DIVA Laboratories Ltd

Healthcare Biotechnology Taiwan OTC Exchange
30.25 TWD
Close of Nov 6, 2026
29.00 36.40
Market cap
TWD 1.77B
P/E
15.5x
P/B
1.85x
ROE
11.4%
Dividend yield
6.61%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 4153.TWO undervalued?

Graham number
Price30.25
Graham value26.82
Premium12.8%

4153.TWO trades 12.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DIVA Laboratories Ltd fundamental analysis

No fundamental analysis for DIVA Laboratories Ltd yet.

DIVA Laboratories Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DIVA Laboratories Ltd

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan.

Full company profile